Business Wire | May 3, 2021 04:30PM EDT

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

May 03, 2021

BRISBANE, Calif.--(BUSINESS WIRE)--May 03, 2021--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences:

* BofA Securities 2021 Health Care Conference Date: Thursday, May 13th at 1:15 p.m. Eastern Time

* 2021 RBC Capital Markets Global Healthcare Conference Date: Tuesday, May 18th at 9:45 a.m. Eastern Time

For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005585/en/

CONTACT: Investor Relations & Media Inquiries Aron Feingold 628.252.7494 afeingold@sangamo.com